Literature DB >> 27346602

The neuropharmacology of butyrate: The bread and butter of the microbiota-gut-brain axis?

Roman M Stilling1, Marcel van de Wouw2, Gerard Clarke3, Catherine Stanton4, Timothy G Dinan3, John F Cryan5.   

Abstract

Several lines of evidence suggest that brain function and behaviour are influenced by microbial metabolites. Key products of the microbiota are short-chain fatty acids (SCFAs), including butyric acid. Butyrate is a functionally versatile molecule that is produced in the mammalian gut by fermentation of dietary fibre and is enriched in butter and other dairy products. Butyrate along with other fermentation-derived SCFAs (e.g. acetate, propionate) and the structurally related ketone bodies (e.g. acetoacetate and d-β-hydroxybutyrate) show promising effects in various diseases including obesity, diabetes, inflammatory (bowel) diseases, and colorectal cancer as well as neurological disorders. Indeed, it is clear that host energy metabolism and immune functions critically depend on butyrate as a potent regulator, highlighting butyrate as a key mediator of host-microbe crosstalk. In addition to specific receptors (GPR43/FFAR2; GPR41/FFAR3; GPR109a/HCAR2) and transporters (MCT1/SLC16A1; SMCT1/SLC5A8), its effects are mediated by utilisation as an energy source via the β-oxidation pathway and as an inhibitor of histone deacetylases (HDACs), promoting histone acetylation and stimulation of gene expression in host cells. The latter has also led to the use of butyrate as an experimental drug in models for neurological disorders ranging from depression to neurodegenerative diseases and cognitive impairment. Here we provide a critical review of the literature on butyrate and its effects on multiple aspects of host physiology with a focus on brain function and behaviour. We find fundamental differences in natural butyrate at physiological concentrations and its use as a neuropharmacological agent at rather high, supraphysiological doses in brain research. Finally, we hypothesise that butyrate and other volatile SCFAs produced by microbes may be involved in regulating the impact of the microbiome on behaviour including social communication.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Endocrine; Gut-brain axis; Neuroepigenetics; Nutrition; Sociability; Treg

Mesh:

Substances:

Year:  2016        PMID: 27346602     DOI: 10.1016/j.neuint.2016.06.011

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  185 in total

1.  Colon-delivered short-chain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlled trial.

Authors:  Bram Vervliet; Kristin Verbeke; Lukas Van Oudenhove; Boushra Dalile; Gabriela Bergonzelli
Journal:  Neuropsychopharmacology       Date:  2020-06-10       Impact factor: 7.853

Review 2.  Microbiome, Immunomodulation, and the Neuronal System.

Authors:  Eric Marietta; Irina Horwath; Veena Taneja
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

3.  Differences in gut microbiota composition of laying hen lines divergently selected on feather pecking.

Authors:  Jerine A J van der Eijk; Hugo de Vries; Joergen B Kjaer; Marc Naguib; Bas Kemp; Hauke Smidt; T Bas Rodenburg; Aart Lammers
Journal:  Poult Sci       Date:  2019-12-01       Impact factor: 3.352

Review 4.  Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.

Authors:  Vincent C Lombardi; Kenny L De Meirleir; Krishnamurthy Subramanian; Sam M Nourani; Ruben K Dagda; Shannon L Delaney; András Palotás
Journal:  J Nutr Biochem       Date:  2018-04-19       Impact factor: 6.048

Review 5.  Recommendations for evaluation of bladder and bowel function in pre-clinical spinal cord injury research.

Authors:  Gregory M Holmes; Charles H Hubscher; Andrei Krassioukov; Lyn B Jakeman; Naomi Kleitman
Journal:  J Spinal Cord Med       Date:  2019-09-26       Impact factor: 1.985

Review 6.  Prebiotic Intake in Older Adults: Effects on Brain Function and Behavior.

Authors:  Monica C Serra; Joe R Nocera; Jessica L Kelleher; Odessa Addison
Journal:  Curr Nutr Rep       Date:  2019-06

7.  When pharmacology meets the microbiome: new targets for therapeutics?

Authors:  Niall P Hyland; John F Cryan
Journal:  Br J Pharmacol       Date:  2018-12       Impact factor: 8.739

8.  Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.

Authors:  Marcel van de Wouw; Marcus Boehme; Joshua M Lyte; Niamh Wiley; Conall Strain; Orla O'Sullivan; Gerard Clarke; Catherine Stanton; Timothy G Dinan; John F Cryan
Journal:  J Physiol       Date:  2018-08-28       Impact factor: 5.182

Review 9.  Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration.

Authors:  Timothy G Dinan; John F Cryan
Journal:  J Physiol       Date:  2016-12-04       Impact factor: 5.182

10.  Anemia in infancy is associated with alterations in systemic metabolism and microbial structure and function in a sex-specific manner: an observational study.

Authors:  Shannon McClorry; Nelly Zavaleta; Alejandro Llanos; Martin Casapía; Bo Lönnerdal; Carolyn M Slupsky
Journal:  Am J Clin Nutr       Date:  2018-12-01       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.